Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Department of Orthopedics, Martini Hospital, Groningen, The Netherlands.
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003074.
Knee distraction treatment for end-stage osteoarthritis successfully postpones arthroplasty for years. Studies performed thus far used general intended use, patient-personalised or custom-made devices. In this study, for the first time, a device specifically designed for knee distraction is evaluated.
65 patients (≤65 years) with end-stage knee osteoarthritis indicated for arthroplasty received knee distraction. Before, 1-year and 2-year post-treatment, questionnaires were filled out and knee radiographs made. Adverse events and self-reported pain medication were registered.
Forty-nine patients completed 2-year follow-up: one patient did not complete treatment, three patients received arthroplasty in the first and four patients in the second year follow-up. Eight patients were lost to follow-up in the second year. The total Western Ontario and McMaster Universities Osteoarthritis Index score showed a clinically relevant improvement at 1 and 2 years (+26 and +24 points), as did all subscales (all p<0.001). The minimum radiographic joint space width improved over 1 (+0.5 mm; p<0.001) and 2 (+0.4 mm; p=0.015) years, as did the physical Short-Form 36 (+10 points; p<0.001). The most common adverse event was pin tract infection, experienced by 66% of patients, in 88% successfully treated with oral antibiotics. In two cases, hospitalisation and/or intravenous antibiotics were needed. Eight patients experienced device-related complications. None of the complications influenced 2-year outcomes. Before treatment, 42% of patients used pain medication, which had nearly been halved 1 (23%; p=0.02) and 2 years (29%; p=0.27) post-treatment.
Patients treated with a general applicable, for knee distraction purpose-built device showed, despite adverse events, significant clinical and structural improvement over 2 years.
NL7986.
膝关节牵伸治疗终末期骨关节炎可成功地将关节置换术推迟数年。迄今为止进行的研究使用了通用的预期用途、患者个性化或定制设备。在这项研究中,首次评估了一种专门为膝关节牵伸设计的设备。
65 名(≤65 岁)患有终末期膝关节骨关节炎且需要关节置换的患者接受了膝关节牵伸治疗。在治疗前、治疗后 1 年和 2 年,患者填写了问卷并拍摄了膝关节 X 光片。记录了不良事件和自我报告的止痛药物使用情况。
49 名患者完成了 2 年随访:1 名患者未完成治疗,3 名患者在第 1 年随访时接受了关节置换,4 名患者在第 2 年随访时接受了关节置换。第 2 年有 8 名患者失访。总的 Western Ontario and McMaster Universities Osteoarthritis Index 评分在 1 年和 2 年均显示出有临床意义的改善(分别增加了 26 分和 24 分),所有子量表也均如此(均 p<0.001)。1 年(+0.5 毫米;p<0.001)和 2 年(+0.4 毫米;p=0.015)时的最小放射学关节间隙宽度也有所改善,身体 Short-Form 36 也增加了 10 分(p<0.001)。最常见的不良事件是针道感染,66%的患者出现这种情况,88%的患者经口服抗生素成功治疗。有两例需要住院治疗和/或静脉注射抗生素。8 名患者出现了与设备相关的并发症。没有一种并发症影响 2 年的结果。治疗前,42%的患者使用止痛药物,1 年后(23%;p=0.02)和 2 年后(29%;p=0.27)几乎减半。
使用通用、专为膝关节牵伸设计的设备治疗的患者在 2 年内显示出显著的临床和结构改善,尽管存在不良事件。
NL7986。